All In Biotech

Free tool

FAERS Monitor: Ferriprox

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021825 or its brand name (Ferriprox, Deferiprone). Reports on generic versions are filed under their own applications.

Reports

3,286

Serious

2,205

67% of reports

Hospitalization

1,251

Death reported

381

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,187
  • death238
  • sickle cell anaemia with crisis218
  • nausea178
  • agranulocytosis163
  • fatigue149
  • ill-defined disorder147
  • vomiting136
  • neutropenia128
  • pyrexia126
  • prescribed overdose109
  • diarrhoea103
  • abdominal discomfort99
  • arthralgia96
  • treatment noncompliance94

Reports by year received

View as table
YearReports
20052
20062
20072
20086
20097
20105
20118
201216
2013113
201487
2015192
2016138
201792
2018138
2019117
2020124
2021267
2022518
2023349
2024350
2025375
2026378

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,873 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sickle cell anaemia with crisisSignal21889.878.918,799
agranulocytosisSignal16356.648.78,779
prescribed overdoseSignal10936.330.13,684
ill-defined disorderSignal14715.513.31,984
treatment noncomplianceSignal9411.09.0847
off label useSignal1,1878.78.38,406
neutropeniaSignal1286.05.1535
abdominal discomfortSignal993.83.1201
pyrexiaSignal1262.32.096
vomiting1361.91.654
death2381.81.682
arthralgia961.51.215
nausea1781.41.224
fatigue1491.21.06
diarrhoea1031.00.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.